Post-operative liver failure following extensive resections for liver tumours is a rare but significant complication. The only effective treatment is liver transplantation (LT); however, there is a debate about its use given the high mortality compared with the outcomes of LT for chronic liver diseases. Cell therapy has emerged as a possible alternative to LT especially as endogenous hepatocyte proliferation is likely inhibited in the setting of prior chemo/radiotherapy. Both hepatocyte and stem cell transplantations have shown promising results in the experimental setting; however, there are few reports on their clinical application. This review identifies the potential stem cell sources in the body, and highlights the triggering factors that lead to their mobilization and integration in liver regeneration following major liver resections.
Ezzat, T. M., Dhar, D. K., Newsome, P. N., Malago, M., & Olde Damink, S. (2011). Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet? Liver International, 31(6), 773-784. https://doi.org/10.1111/j.1478-3231.2011.02530.x